Rain Oncology
RAIN • XNAS
Rain Oncology is a publicly traded company trading on XNAS, led by CEO Randall Seidl, with a market cap of $22.5M.
CEORandall Seidl
Market Cap$22.5M
Employees63.0
Next Earnings
Upcoming earnings announcement for Rain Oncology
Date
Wednesday, May 20, 2026 (in 2 months)
Timing
Before Market Open (3:05 AM New York)
Fiscal Period
Q1 2026
Earnings History
Past 11 earnings reports for Rain Oncology
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$0.29 | — | - | — | — |
| Aug 14, 2025 | Q2 2025 | -$0.13 | — | - | — | — |
| Nov 9, 2023 | Q3 2023 | -$0.19Est: -$0.27 | +29.6% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.61Est: -$0.51 | -19.6% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.56Est: -$0.61 | +8.2% | - | — | — |
| Mar 9, 2023 | Q4 2022 | -$0.70Est: -$0.56 | -25.0% | - | — | — |
| Nov 10, 2022 | Q3 2022 | -$0.68Est: -$0.68 | 0.0% | - | — | — |
| Aug 4, 2022 | Q2 2022 | -$0.66Est: -$0.66 | 0.0% | - | — | — |
| May 4, 2022 | Q1 2022 | -$0.66Est: -$0.70 | +5.7% | - | — | — |
| Mar 3, 2022 | Q4 2021 | -$0.68Est: -$0.56 | -21.4% | - | — | — |
| Nov 10, 2021 | Q3 2021 | -$0.70Est: -$0.64 | -9.4% | - | — | — |